Shanghai-based NOD Pharmaceuticals Inc. has announced that the U.S. Patent and Trademark Office has approved the patent application for its nano-particle oral delivery technology.

Sinovac Biotech, a developer and provider of vaccines in China, has received a certificate of approval from the Secretaria de Salud to distribute PANFLU.1, its H1N1 pandemic influenza (swine flu) vaccine, in Mexico.

Sweden-based Orexo and the Chinese pharmaceutical company NovaMed Pharmaceuticals have signed an exclusive licensing and distribution agreement that grants NovaMed rights to seek approval for the marketing and distributing of Abstral Orexo´s product for treatment of breakthrough cancer pain in mainland China and, if granted, to market and sell the product in that market.

China RuiTai International Holdings Co., Ltd., a producer and distributor of cellulose ether products in China, has announced that it has completed a pilot test for biopolysaccharide, which is ready for mass production.